Morgan Lewis partner Bob Hibbert authored an article for Law360 about the recent formal agreement between the US Food and Drug Administration and the US Department of Agriculture detailing the division of responsibility between the two agencies over the emerging and much-discussed category of human food produced using cell culture technology, derived from cell lines of USDA-amenable species and required to bear a USDA mark of inspection.